Next Article in Journal
Sulfated-Polysaccharide Fraction from Red Algae Gracilaria caudata Protects Mice Gut Against Ethanol-Induced Damage
Next Article in Special Issue
Examination of Marine-Based Cultivation of Three Demosponges for Acquiring Bioactive Marine Natural Products
Previous Article in Journal
An Acute Case of Intoxication with Cyanobacteria and Cyanotoxins in Recreational Water in Salto Grande Dam, Argentina
Previous Article in Special Issue
Kinase Inhibitors from Marine Sponges
Article Menu

Export Article

Correction published on 7 May 2013, see Mar. Drugs 2013, 11(5), 1490-1491.

Open AccessReview
Mar. Drugs 2011, 9(11), 2176-2187; doi:10.3390/md9112176

Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review

1
Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National University, Jeju 690-756, Korea
2
Department of Urology, Chungbuk National University College of Medicine, Cheongju 361-763, Korea
3
Department of Biochemistry, College of Oriental Medicine, Dongeui University, Busan 614-052, Korea
4
Department of Biomaterial Control (BK21 program), Graduate School, and Blue-Bio Industry RIC, Dongeui University, Busan 614-052, Korea
*
Author to whom correspondence should be addressed.
Received: 2 September 2011 / Revised: 9 October 2011 / Accepted: 19 October 2011 / Published: 2 November 2011
(This article belongs to the Special Issue Bioactive Compounds from Marine Sponges)
View Full-Text   |   Download PDF [312 KB, uploaded 24 February 2015]   |  

Abstract

Pectenotoxin-2 (PTX-2), which was first identified as a cytotoxic entity in marine sponges, has been reported to display significant cytotoxicity to human cancer cells where it inhibits mitotic separation and cytokinesis through the depolymerization of actin filaments. In the late stage of endoreduplication, the effects of PTX-2 on different cancer cells involves: (i) down-regulation of anti-apoptotic Bcl-2 members and IAP family proteins; (ii) up-regulation of pro-apoptotic Bax protein and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor 1/receptor 2 (DR4/DR5); and (iii) mitochondrial dysfunction. In addition, PTX-2 induces apoptotic effects through suppression of the nuclear factor κB (NF-κB) signaling pathway in several cancer cells. Analysis of cell cycle regulatory proteins showed that PTX-2 increases phosphorylation of Cdc25c and decreases protein levels of Cdc2 and cyclin B1. Cyclin-dependent kinase (Cdk) inhibitor p21 and Cdk2, which are associated with the induction of endoreduplication, were upregulated. Furthermore, it was found that PTX-2 suppressed telomerase activity through the transcriptional and post-translational suppression of hTERT. The purpose of this review was to provide an update regarding the anti-cancer mechanism of PTX-2, with a special focus on its effects on different cellular signaling cascades. View Full-Text
Keywords: pectenotoxin-2; cancer; cell cycle; apoptosis pectenotoxin-2; cancer; cell cycle; apoptosis
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Kim, G.-Y.; Kim, W.-J.; Choi, Y.H. Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review. Mar. Drugs 2011, 9, 2176-2187.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top